Mathumai Kanapathipillai

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Exosome-Coated tPA/Catalase Nanoformulation for Thrombolytic Therapy”.

Exosome-Coated tPA/Catalase Nanoformulation for Thrombolytic Therapy

Bioengineering(2023)10.3390/bioengineering10020177

N/A

0DataRank · unranked

12 citations

Mathumai Kanapathipillai, Sara Khalil

Amyloid-like RIP1/RIP3 RHIM Fragments’ Characterization and Application as a Drug Depot

Molecules(2023)10.3390/molecules28031480

N/A

0DataRank · unranked

5 citations

Mathumai Kanapathipillai, Maytham Ismail

Effect of extracellular matrices on production and potency of mesenchymal stem cell‐derived exosomes

Biotechnology Journal(2024)10.1002/biot.202300474

N/A

0DataRank · unranked

6 citations

Lina Faraj, Saurav Datta, Mathumai Kanapathipillai, Gargi Ghosh, Rittika Somadder

Novel Ultrasound-Responsive Amyloid Formulation

Pharmaceuticals(2024)10.3390/ph17060777

N/A

0DataRank · unranked

3 citations

Mathumai Kanapathipillai, Maytham Ismail

A preliminary investigation into the activity and toxicity of an amyloid-based Emodin formulation

Toxicon(2025)10.1016/j.toxicon.2025.108308

N/A

0DataRank · unranked

1 citations

Alejandro Hinojosa, Maytham Ismail, Venkateshwar G. Keshamouni, Mathumai Kanapathipillai, Anderson Gattis

Lysozyme Amyloid for Synthetic RNA Delivery

Pharmaceutics(2025)10.3390/pharmaceutics17091094

N/A

0DataRank · unranked

1 citations

Maytham Ismail, Sergei Chuikov, Venkateshwar G. Keshamouni, Mathumai Kanapathipillai, Benjamin Beluzo